 associ hepat surfac antigen core antibodi acquisit manifest human immunodefici viru type infect associ seroposit hepat viru hbv presenc develop antibodi human immunodefici viru t-helper lymphocyt defici immunodefici syndrom aid serolog data hbv cytometr enumer lymphocyt clinic event aid diseas control criteria hepat vaccin histori avail homosexu particip multicent aid cohort studi men previou infect hbv preval incid infect associ seroposit hbv infect infect enrol odd ratio anti-hbc hbsag relat hbv seroposit subsequ seroconvers odd ratio seroconvers histori certain diseas sexual practic associ hbv infect seroposit hbv infect entri low rapid subsequ declin t-helper lymphocyt count increas incid aid year follow-up histori vaccin hbv suscept infect subsequ progress immunodefici prior hbv infect unlik acquisit infect unrel rapid progress immunodefici